Huadong Medicine Co., Ltd (SHE:000963)
41.45
+0.29 (0.70%)
At close: Dec 12, 2025
Huadong Medicine Market Cap
Huadong Medicine has a market cap or net worth of 72.53 billion as of December 12, 2025. Its market cap has increased by 17.51% in one year.
Market Cap
72.53B
Enterprise Value
70.80B
Revenue
43.09B
Ranking
n/a
PE Ratio
19.68
Stock Price
41.45
Market Cap Chart
Since January 2, 2001, Huadong Medicine's market cap has increased from 4.21B to 72.53B, an increase of 1,622.66%. That is a compound annual growth rate of 12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 72.53B | 19.78% |
| Dec 31, 2024 | 60.55B | -16.55% |
| Dec 29, 2023 | 72.56B | -11.60% |
| Dec 30, 2022 | 82.09B | 16.70% |
| Dec 31, 2021 | 70.34B | 51.36% |
| Dec 31, 2020 | 46.47B | 8.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 419.80B |
| WuXi AppTec | 279.36B |
| Shenzhen Mindray Bio-Medical Electronics | 241.66B |
| Sichuan Biokin Pharmaceutical | 148.61B |
| Shanghai United Imaging Healthcare | 105.48B |
| Aier Eye Hospital Group | 103.27B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.09B |
| Yunnan Baiyao Group Co.,Ltd | 99.62B |